Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Finished Goods (2022 - 2025)

Historic Finished Goods for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $915839.0.

  • Jin Medical International's Finished Goods fell 3302.44% to $915839.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $915839.0, marking a year-over-year decrease of 3302.44%. This contributed to the annual value of $915839.0 for FY2025, which is 3302.44% down from last year.
  • According to the latest figures from Q3 2025, Jin Medical International's Finished Goods is $915839.0, which was down 3302.44% from $1.4 million recorded in Q3 2024.
  • In the past 5 years, Jin Medical International's Finished Goods ranged from a high of $2.1 million in Q3 2022 and a low of $820949.0 during Q3 2023
  • For the 4-year period, Jin Medical International's Finished Goods averaged around $1.3 million, with its median value being $1.1 million (2024).
  • In the last 5 years, Jin Medical International's Finished Goods crashed by 5996.54% in 2023 and then surged by 6656.59% in 2024.
  • Over the past 4 years, Jin Medical International's Finished Goods (Quarter) stood at $2.1 million in 2022, then plummeted by 59.97% to $820949.0 in 2023, then skyrocketed by 66.57% to $1.4 million in 2024, then crashed by 33.02% to $915839.0 in 2025.
  • Its last three reported values are $915839.0 in Q3 2025, $1.4 million for Q3 2024, and $820949.0 during Q3 2023.